Japanese poor metabolizers of proguanil do not have an increased risk of malaria chemoprophylaxis breakthrough

This publication has 10 references indexed in Scilit:

• Metabolic disposition of proguanil in extensive and poor metabolisers of S‐mephenytoin 4'‐hydroxylation recruited from an Indonesian population.
  British Journal of Clinical Pharmacology, 1995
• Oxidative activation of proguanil and dapsone acetylation in Thai soldiers.
  British Journal of Clinical Pharmacology, 1994
• The multiple dose pharmacokinetics of proguanil.
  British Journal of Clinical Pharmacology, 1993
• The activation of the biguanide antimalarial proguanil co‐segregates with the mephenytoin oxidation polymorphism‐a panel study.
  British Journal of Clinical Pharmacology, 1991
• Variability in the metabolism of proguanil to the active metabolite cycloguanil in healthy Kenyan adults
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1990
• Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese
  Clinical Pharmacology & Therapeutics, 1989
• Inter‐subject variability in the metabolism of proguanil to the active metabolite cycloguanil in man.
  British Journal of Clinical Pharmacology, 1989
• A preliminary pharmacokinetic study of the antimalarial drugs, proguanil and chlorproguanil
  Journal of Pharmacy and Pharmacology, 1987
• A comparison of the pyrimethamine and cycloguanil sensitivities of the pre-erythrocytic and erythrocytic stages of drug-sensitive and -resistant strains ofPlasmodium yoelii
  Pathogens and Global Health, 1985
• Antimalarial Activity and Metabolism of Biguanides
  The American Journal of Tropical Medicine and Hygiene, 1961